As reports increasingly highlight the critical role of P2X7 and ATP in tumor biology and its microenvironment, the rationale for targeting P2X7 in cancer in single or combination therapies is becoming increasingly relevant (Di Virgilio et al., 2017; Li et al., 2019). The gene discussed is P2RX7; the disease is cancer.